Prebiotic effect analysis

Details for Australian Patent Application No. 2004280375 (hide)

Owner Novartis AG

Inventors Gibson, Glenn R.; Rastall, Robert; Vulevic, Jelena

Agent Davies Collison Cave

Pub. Number AU-B-2004280375

PCT Pub. Number WO2005/035781

Priority 0401867.7 28.01.04 GB; 0323089.3 02.10.03 GB

Filing date 1 October 2004

Wipo publication date 21 April 2005

Acceptance publication date 15 May 2008

International Classifications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/035781 Priority application(s): WO2005/035781

15 May 2008 Application Accepted

  Published as AU-B-2004280375

30 October 2008 Standard Patent Sealed

29 January 2009 Assignment before Grant

  Novartis AG The application has been assigned to Nestec S.A. 2005

29 January 2009 Standard Patent Sealed

29 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004280399-Method for producing Ti or Ti alloy through reduction by Ca

2004280373-Process for activating a hydrotreating catalyst